Pfizer SARS-CoV-2 protease inhibitor PF-07321332 and SARS-CoV-2 protease, molecular models. The image shows the protease (top) and the inhibitor (bottom). As of 2021, the clinical candidate PF-07321332 is a potent protease inhibitor with potent anti-viral activity against SARS-CoV-2.
px | px | dpi | = | cm | x | cm | = | MB |
Details
Creative#:
TOP27148702
Source:
達志影像
Authorization Type:
RM
Release Information:
須由TPG 完整授權
Model Release:
N/A
Property Release:
N/A
Right to Privacy:
No
Same folder images: